20174894 | Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adenomas. | Endocr Pathol | 2010 Mar | Dallago CM | doi: 10.1007/s12022-010-9107-x. |
21866463 | Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour. | Pol J Pathol | 2011 | Taran K | - |
16882345 | Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. | BMC Cancer | 2006 Aug 1 | Yang J | - |
20694513 | MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. | Dig Dis Sci | 2011 Mar | Giaginis C | doi: 10.1007/s10620-010-1348-5 |
27065331 | Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. | Oncogene | 2016 Oct 13 | Liu F | doi: 10.1038/onc.2016.80 |
21868526 | Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer. | Anticancer Res | 2011 Sep | Werynska B | - |
18286467 | Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells. | J Cell Biochem | 2008 Jun 1 | Charych DH | doi: 10.1002/jcb.21698. |
24706378 | Correlation of MCM2 detection with stage and virology of cervical cancer. | Int J Biol Markers | 2014 Dec 9 | Amaro Filho SM | doi: 10.5301/jbm.5000081. |
23329420 | MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. | Histol Histopathol | 2013 Apr | Liu M | doi: 10.14670/HH-28.481 |
18465232 | Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity. | Dig Dis Sci | 2009 Feb | Giaginis C | doi: 10.1007/s10620-008-0305-z |
23770000 | MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. | Toxicol Lett | 2013 Jul 31 | Liu Y | doi: 10.1016/j.toxlet.2013.05.643 |
24630889 | MCM2/TOP2A (ProExC) immunohistochemistry as a predictive marker in head and neck mucosal biopsies. | Pathol Res Pract | 2014 Jun | Jenson EG | doi: 10.1016/j.prp.2014.02.003 |
22554381 | Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases. | Hum Pathol | 2012 Nov | Toubaji A | doi: 10.1016/j.humpath.2012.01.007 |
19077563 | mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma. | Eur J Cancer Prev | 2009 Feb | Wang Y | doi: 10.1097/CEJ.0b013e32830c8d5a. |
27748889 | MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder. | Mol Med Rep | 2016 Nov | Liu Z | doi: 10.3892/mmr.2016.5851 |
29393493 | Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer. | Oncol Rep | 2018 Apr | Zhong A | doi: 10.3892/or.2018.6229 |
28910940 | [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection]. | Zhonghua Liu Xing Bing Xue Za Zhi | 2017 Sep 10 | Wang HR | doi: 10.3760/cma.j.issn.0254-6450.2017.09.020. |